China has given conditional approval for the general public use of a Covid-19 vaccine developed by Sinovac Biotech, making it the second home-made vaccine to get the green light for mass inoculation.
On Dec.6, Wang Junzhi said during a Coronavirus Vaccine Development Conference that “Breaking news will be announced within the coming weeks and 600 million inactivated vaccines (killed virus) will go public within this year.”